Submitted:
28 July 2026
Posted:
30 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods

2.1. Limitations
3. Results
3.1. Characteristics of the Study Group
3.2. Results of Univariate Analysis
3.3. Results of Multivariate Analysis
- AGE: Each one-year increase in age was associated with a 2% increase in the odds of the disorder (OR = 1.02; 95% CI: 1.01–1.02; p < 0.0001).
- BMI category “overweight”: Compared to individuals with normal BMI, overweight was a protective factor, associated with a 15% reduction in the odds of the disorder (OR = 0.85; 95% CI: 0.73–1.00; p = 0.0444).
- Number of full-term pregnancies: A higher number of full-term pregnancies was a significant protective factor. Each additional full-term pregnancy was associated with a 35% decrease in the odds of the disorder (OR = 0.65; 95% CI: 0.60–0.69; p < 0.0001). In other words, individuals with a lower number of full-term pregnancies had a 54% higher odds of the disorder.
3.4. Assessment of Predictive Value Using U-SmILE Plots
- BMI categories improved classification to the healthy group by 0.2%, with no significant effect on classification to the group with disorders.
- Smoking improved classification to the healthy group by 0.2%, with no significant effect on classification to the group with disorders.
- Miscarriages improved classification to the healthy group by 0.2%, with no significant effect on classification to the group with disorders.
- Preterm births improved classification to the healthy group only by 0.1%, with no significant effect on classification to the group with disorders.
4. Discussion
4.1. BMI
4.2. Miscarriages
4.3. Preterm Births
4.4. Term Births
4.5. Smoking
4.6. Age
5. Conclusions
- In the multivariable logistic regression analysis, overweight was identified as an independent protective factor for pelvic organ prolapse (POP). Compared with women with normal body mass index (BMI), those classified as overweight had a 15% lower likelihood of developing POP (OR = 0.85, 95% CI: 0.73–1.00; p = 0.0444). In contrast, underweight was not significantly associated with the occurrence of POP.
- Neither miscarriage nor preterm delivery emerged as independent risk factors for POP after adjustment for the remaining covariates included in the model. Similarly, smoking status was not independently associated with the presence of POP.
- Among all variables examined, the number of term pregnancies was the strongest independent predictor of POP. Each additional term pregnancy was associated with a 35% reduction in the odds of POP (OR = 0.65, 95% CI: 0.60–0.69; p < 0.0001). Conversely, women with fewer term pregnancies had a substantially greater likelihood of developing POP.
- Increasing age was also identified as an independent risk factor, with each additional year associated with a 2% increase in the odds of POP (OR = 1.02, 95% CI: 1.01–1.02; p < 0.0001).
- The remaining variables included in the regression model, namely obesity, underweight, miscarriage, preterm pregnancy, and smoking, did not reach statistical significance, indicating that they were not independent predictors of POP in the studied population.
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| POP | Pelvic Organ Prolapse |
| SUI | Stress Urinary Incontinence |
| LUTS | Lower Urinary Tract Symptoms |
| BMI | Body Mass Index |
References
- Jakub Mroczyk, Grażyna Jarząbek-Bielecka, Piotr Merks et al. Analysis of selected factors in pelvic organ prolapse and urinary incontinence and the differentiation of clinical forms – a pilot study, 26 July 2026, PREPRINT (Version 1) available at Research Square.
- Przydacz, M.; et al. Percepcja objawów z dolnego odcinka dróg moczowych (Lower Urinay Tract Symptoms - LUTS) przez lekarzy psychiatrów. [CrossRef]
- Kubiak, K.B.; Więckowska, B.; Jodłowska-Siewert, E.; et al. Visualising and quantifying the usefulness of new predictors stratified by outcome class: The U-smile method. PLoS ONE 2024, 19, e0303276. [Google Scholar] [CrossRef] [PubMed]
- Więckowska, B.; Kubiak, K.B.; Guzik, P. Evaluating the three-level approach of the U-smile method for imbalanced binary classification. PLoS ONE 2025, 20, e0321661. [Google Scholar] [CrossRef] [PubMed]
- Więckowska, B.; Guzik, P. U-smile – nowa metoda oceny zmiennej predykcyjnej bez progu decyzyjnego: wizualizacja i interpretacja za pomocą współczynnika rLR. Kongr. Stat. Pol. 2025. [Google Scholar] [CrossRef]
- World Health Organization. International statistical classification of diseases and related health problems. 10th revision (ICD-10), 5th ed.; World Health Organization: Geneva, 2016. [Google Scholar]
- Dizdaroullar, G.E.; Çam, Ç.; Ayvac?, H.; et al. The Importance of BMI on Prognostic Factors for Urinary Incontinence in Asymptomatic Nulliparous Women. J. Clin. Ultrasound 2025. [Google Scholar] [CrossRef] [PubMed]
- Hamoda, R.E.; Saad, E.A.; Kamel, D.M. Impact of BMI on Vaginal Noise and POP Symptoms. Bull. Fac. Phys. Ther. 2024. [Google Scholar] [CrossRef]
- Taithongchai, A.; Johnson, E.E.; Ismail, S.I.; Wallace, S.A.; Thakar, R. Oestrogen therapy for preventing pelvic organ prolapse in postmenopausal women. Cochrane Database Syst. Rev. 2024, 2024(2), CD015695, Published 2024 Feb 15. [Google Scholar] [CrossRef]
- Dietz, H.P.; Shek, K.L.; Descallar, J. Levator–Urethra Gap and Individualized Cut-Offs. Ultrasound Obstet. Gynecol. 2024. [Google Scholar] [CrossRef] [PubMed]
- Henok, A. Prevalence and Factors Associated with Pelvic Organ Prolapse among Pedestrian Back-Loading Women in Bench Maji Zone. Ethiop. J. Health Sci. 2017, 27(3), 263–272. [Google Scholar] [CrossRef] [PubMed]
- Puri, R. Risk factors for uterine prolapse among women in a hill village of Nepal: A case–control study. J. Obstet. Gynaecol. Res. 2011, 37(10), 1323–1330. [Google Scholar]
- Paudel, R.; Bhandari, S.; Paudel, L.; Thapa, B.; Bista, K.D. Risk factors of uterine prolapse among reproductive age group women in rural Nepal: A community-based case–control study. Int. Urogynecol. J. 2019, 30(10), 1681–1688. [Google Scholar]
- Siahkal, S.F.; Iravani, M.; Mohaghegh, Z.; Rashidi-Fakari, F. Maternal, obstetrical and neonatal risk factors’ impact on female urinary incontinence: a systematic review. Int. Urogynecology J. 2020, 31(12), 2513–2523. [Google Scholar] [CrossRef] [PubMed]
- Kiliç, M. Incidence and risk factors of urinary incontinence in women visiting Family Health Centers. SpringerPlus 2016, 5, 1331. [Google Scholar] [CrossRef] [PubMed]
- Abdullah, B.; Ayub, S.H.; Zahid, A.Z.M.; Noorneza, A.R. Urinary incontinence in primigravida: the neglected pregnancy predicament. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016, 200, 25–29. [Google Scholar] [CrossRef] [PubMed]
- Dai, S.; Chen, H.; Luo, T. Prevalence and factors of urinary incontinence among postpartum: systematic review and meta-analysis. BMC Pregnancy Childbirth 2023, 23(1), 59. [Google Scholar] [CrossRef] [PubMed]
- Workineh, Z. A.; Gashaw, Z. M.; Andargie, T. M.; et al. Symptomatic pelvic floor disorders in community-dwelling women in Central Gondar Zone, Northwest Ethiopia. Int. Urogynecology Journal. 2025. [Google Scholar] [CrossRef] [PubMed]
- Hagen, S.; Sellers, C.; Elders, A.; et al. Urinary incontinence, faecal incontinence and pelvic organ prolapse symptoms 20–26 years after childbirth. BJOG An. Int. J. Obstet. Gynaecol. 2024. [Google Scholar] [CrossRef] [PubMed]
- Schulten, S. F. M.; et al. Pelvic organ prolapse and prolapse recurrence: an updated systematic review and meta-analysis; Expert Reviews, 2022. [Google Scholar] [PubMed]
- Fitz, F.F.; Bortolini, M.A.T.; et al. Lifestyle and comorbidities as risk factors for pelvic organ prolapse: A systematic review. Int. Urogynecol J. 2023. [Google Scholar] [CrossRef] [PubMed]
- Carnevali, S.; Nakamura, Y.; Mio, T.; Liu, X.; Takigawa, K.; Romberger, D. J.; Spurzem, J. R.; Rennard, S. I. Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am. J. Physiol. 1998, 274(4), L591–L598. [Google Scholar] [CrossRef] [PubMed]
- Rodríguez-Mias, N.L.; et al. Do POP and SUI share the same risk factors? Eur. J. Obstet. Gynecol. Reprod. Biol. 2015. [Google Scholar] [PubMed]
- Bręborowicz, G.H. (Ed.) Położnictwo i ginekologia; PZWL Wydawnictwo Lekarskie: Warszawa, 2021; Vol. 2. [Google Scholar]
- Ansari, M.K.; Sharma, P.P.; Khan, S. Pelvic Organ Prolapse in Perimenopausal and Menopausal Women. J. Obstet. Gynaecol. India 2022, 72(3), 250–257. [Google Scholar] [CrossRef] [PubMed]


| ICD-10 | Study Group | Control Group | Total |
|---|---|---|---|
| E28.1. Androgen excess |
0 | 1 | 1 |
| E28.2. Polycystic ovarian syndrome |
0 | 7 | 7 |
| E28.3. Primary ovarian failure |
0 | 14 | 14 |
| E28.8. Other ovarian dysfunction |
0 | 3 | 3 |
| E28.9. Ovarian dysfunction, unspecified |
0 | 1 | 1 |
| N39.3. Stress incontinence |
1328 | 0 | 1328 |
| N63. Unspecified lump in breast |
0 | 157 | 157 |
| N64.3. Galactorrhea not associated with childbirth |
0 | 3 | 3 |
| N64.4. Mastodynia |
0 | 5 | 5 |
| N64.5. Other signs and symptoms in breast |
0 | 10 | 10 |
| N64.8. Other specified disorders of breast |
0 | 9 | 9 |
| N64.9. Disorder of breast, unspecified |
0 | 14 | 14 |
| N76.0. Acute vaginitis |
0 | 85 | 85 |
| N76.1. Subacute and chronic vaginitis |
0 | 8 | 8 |
| N76.2. Acute vulvitis |
0 | 7 | 7 |
| N76.3. Subacute and chronic vulvitis |
0 | 3 | 3 |
| N76.4. Abscess of vulva |
0 | 7 | 7 |
| N76.5. Ulceration of vagina |
0 | 106 | 106 |
| N76.6. Ulceration of vulva |
0 | 14 | 14 |
| N76.8. Other specified inflammation of vagina and vulva |
0 | 33 | 33 |
| N8.1. Cystocele |
1121 | 0 | 1121 |
| N8.2. Incomplete uretrovaginal prolapse |
442 | 0 | 442 |
| N81.3. Complete uterovaginal prolapse |
359 | 0 | 359 |
| N81.4. Uterovaginal prolapse, unspecified |
176 | 0 | 176 |
| N81.5. Vaginal enterocele |
34 | 0 | 34 |
| N81.6. Rectocele |
435 | 0 | 435 |
| N81.8. Other female genital prolapse |
59 | 0 | 59 |
| N81.9. Female genital prolapse, unspecified |
379 | 0 | 379 |
| N90.0. Mild vulvar dysplasia |
0 | 12 | 12 |
| N90.1. Moderate vulvar dysplasia |
0 | 7 | 7 |
| N90.2. Severe vulvar dysplasia, not elsewhere classified |
0 | 27 | 27 |
| N90.3. Dysplasia of vulva, unspecified |
0 | 49 | 49 |
| N90.4. Leukoplakia of vulva |
0 | 150 | 150 |
| N90.5. Atrophy of vulva |
0 | 27 | 27 |
| N90.6. Hypertrophy of vulva |
0 | 9 | 9 |
| N90.7. Vulvar cyst |
0 | 3 | 3 |
| N90.8. Other specified noninflammatory disorders of vulva and perineum |
0 | 154 | 154 |
| N90.9. Noninflammatory disorder of vulva and perineum, unspecified |
0 | 219 | 219 |
| Total | 4333 | 1144 | 5477 |
| BMI | Study Group | Control Group | Total |
|---|---|---|---|
| Underweight | 23 | 10 | 33 |
| Normal weight | 1448 | 411 | 1859 |
| Overweight | 1833 | 443 | 2276 |
| Obesity | 1029 | 280 | 1309 |
| Total | 4333 | 1144 | 5477 |
| Full-term pregnancies | Study Group | Control Group | Total |
|---|---|---|---|
| 0 | 140 | 149 | 289 |
| 1 | 648 | 233 | 881 |
| 2 | 2205 | 511 | 2716 |
| 3 | 936 | 194 | 1330 |
| 4 | 280 | 47 | 327 |
| 5 | 79 | 7 | 86 |
| 6 | 26 | 2 | 28 |
| 7 | 11 | 1 | 12 |
| 8 | 3 | 0 | 3 |
| 9 | 2 | 0 | 2 |
| 10 | 2 | 0 | 2 |
| 12 | 1 | 0 | 1 |
| Total | 4333 | 1144 | 5477 |
| Preterm births | Study Group | Control Group | Total |
|---|---|---|---|
| 0 | 4063 | 1061 | 5124 |
| 1 | 219 | 70 | 289 |
| 2 | 43 | 12 | 55 |
| 3 | 6 | 1 | 7 |
| 4 | 2 | 0 | 2 |
| Total | 4333 | 1144 | 5477 |
| Miscarriages | Study Group | Control Group | Total |
|---|---|---|---|
| 0 | 3481 | 948 | 4429 |
| 1 | 630 | 154 | 784 |
| 2 | 160 | 29 | 189 |
| 3 | 48 | 11 | 59 |
| 4 | 10 | 0 | 10 |
| 5 | 4 | 2 | 6 |
| Total | 4333 | 1144 | 5477 |
| Smoking | Study Group | Control Group | Total |
|---|---|---|---|
| No | 4043 | 1062 | 4429 |
| Yes | 290 | 82 | 784 |
| Total | 4333 | 1144 | 5477 |
| Variable | Measures | Study group | Control group | p-value | test |
|---|---|---|---|---|---|
| Age | 0,001555579 | p (Mann-Whitney) |
|||
| Mean ± SD | 62.72±12.66 | 64.68±9.76 | |||
| Median [Q1; Q3] |
65 [53; 72] |
64 [56; 72] |
|||
| Median [Min; Max] |
65[26; 95] |
64[51; 93] |
| Variable | Categories | Study group | Control group | p-value | test |
|---|---|---|---|---|---|
| Full-term pregnancies | <0.0001 | p (Mann-Whitney) |
|||
| 0 | 140(3.23%) | 149(13.02%) | |||
| 1 | 648(14.95%) | 233(20.37%) | |||
| 2 | 2205(50.89%) | 511(44.67%) | |||
| 3 | 936(21.6%) | 194(16.96%) | |||
| 4 | 280(6.46%) | 47(4.11%) | |||
| 5 | 79(1.82%) | 7(0.61%) | |||
| 6 | 26(0.6%) | 2(0.17%) | |||
| 7 | 11(0.25%) | 1(0.09%) | |||
| 8 | 3(0.07%) | 0 | |||
| 9 | 2(0.05%) | 0 | |||
| 10 | 2(0.05%) | 0 | |||
| 11 | 0 | 0 | |||
| 12 | 1(0.02%) | 0 |
| Variable | Categories | Study group | Control group | p-value | test |
|---|---|---|---|---|---|
| Miscarriages | 0.041201596 | p (Mann-Whitney) |
|||
| 0 | 3481(80.34%) | 948(82.87%) | |||
| 1 | 630(14.54%) | 154(13.46%) | |||
| 2 | 160(3.69%) | 29(2.53%) | |||
| 3 | 48(1.11%) | 11(0.96%) | |||
| 4 | 10(0.23%) | 0 | |||
| 5 | 4(0.09%) | 2(0.17%) |
| Category | OR [95%Cl] | Wald test p-value |
|---|---|---|
| Age |
1.02[1.01; 1.02] | <0.0001 |
| BMI category - underweight |
1.75[0.82; 3.78] | 0.1503 |
| BMI category - normal |
reference | reference |
| BMI category - overweight |
0.85[0.73; 1] | 0.0444 |
| BMI category - obesity |
1.03[0.87; 1.23] | 0.7104 |
| Full-term pregnancies |
0.65[0.6; 0.69] | <0.0001 |
| Preterm births |
0.84[0.68; 1.03] | 0.0929 |
| Miscarriages |
0.91[0.81; 1.03] | 0.1252 |
| Smoking | 1.13[0.87; 1.46] | 0.3595 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).